These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15844444)

  • 1. 3D QSAR investigation of the blood-brain barrier penetration of chemical compounds.
    Lessigiarska I; Pajeva I; Cronin MT; Worth AP
    SAR QSAR Environ Res; 2005; 16(1-2):79-91. PubMed ID: 15844444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D-QSAR study of bis-azaaromatic quaternary ammonium analogs at the blood-brain barrier choline transporter.
    Geldenhuys WJ; Lockman PR; Nguyen TH; Van der Schyf CJ; Crooks PA; Dwoskin LP; Allen DD
    Bioorg Med Chem; 2005 Jul; 13(13):4253-61. PubMed ID: 15878282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of anthranilamide derivatives that are multidrug resistance modulators.
    Labrie P; Maddaford SP; Fortin S; Rakhit S; Kotra LP; Gaudreault RC
    J Med Chem; 2006 Dec; 49(26):7646-60. PubMed ID: 17181148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous system.
    Allen DD; Geldenhuys WJ
    Life Sci; 2006 Feb; 78(10):1029-33. PubMed ID: 16126231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling of phenothiazines and related drugs as multidrug resistance modifiers: a comparative molecular field analysis study.
    Pajeva I; Wiese M
    J Med Chem; 1998 May; 41(11):1815-26. PubMed ID: 9599232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR and 3D-QSAR of phenothiazine type multidrug resistance modulators in P388/ADR cells.
    Tsakovska IM
    Bioorg Med Chem; 2003 Jul; 11(13):2889-99. PubMed ID: 12788359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constructing optimum blood brain barrier QSAR models using a combination of 4D-molecular similarity measures and cluster analysis.
    Pan D; Iyer M; Liu J; Li Y; Hopfinger AJ
    J Chem Inf Comput Sci; 2004; 44(6):2083-98. PubMed ID: 15554679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ionization-specific QSAR models of blood-brain penetration of drugs.
    Lanevskij K; Japertas P; Didziapetris R; Petrauskas A
    Chem Biodivers; 2009 Nov; 6(11):2050-4. PubMed ID: 19937840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive model of blood-brain barrier penetration of organic compounds.
    Ma XL; Chen C; Yang J
    Acta Pharmacol Sin; 2005 Apr; 26(4):500-12. PubMed ID: 15780201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR studies on P-glycoprotein-regulated multidrug resistance and on its reversal by phenothiazines.
    Dearden JC; Al-Noobi A; Scott AC; Thomson SA
    SAR QSAR Environ Res; 2003; 14(5-6):447-54. PubMed ID: 14758987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling of triazine type MDR modulators using CoMFA and CoMSIA approaches.
    Tsakovska IM; Pajeva IK
    SAR QSAR Environ Res; 2002; 13(3-4):487-98. PubMed ID: 12184389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting penetration across the blood-brain barrier from simple descriptors and fragmentation schemes.
    Zhao YH; Abraham MH; Ibrahim A; Fish PV; Cole S; Lewis ML; de Groot MJ; Reynolds DP
    J Chem Inf Model; 2007; 47(1):170-5. PubMed ID: 17238262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
    Ford JM; Prozialeck WC; Hait WN
    Mol Pharmacol; 1989 Jan; 35(1):105-15. PubMed ID: 2563302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling studies on the active binding site of the blood-brain barrier choline transporter.
    Geldenhuys WJ; Lockman PR; McAfee JH; Fitzpatrick KT; Van der Schyf CJ; Allen DD
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3085-92. PubMed ID: 15149650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of a series of tariquidar analogs as multidrug resistance modulators.
    Globisch C; Pajeva IK; Wiese M
    Bioorg Med Chem; 2006 Mar; 14(5):1588-98. PubMed ID: 16307883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells.
    Molnár J; Hevér A; Fakla I; Fischer J; Ocsovski I; Aszalós A
    Anticancer Res; 1997; 17(1A):481-6. PubMed ID: 9066699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional quantitative structure-activity relationship analysis of propafenone-type multidrug resistance modulators: influence of variable selection on test set predictivity.
    Fleischer R; Wiese M
    J Med Chem; 2003 Nov; 46(23):4988-5004. PubMed ID: 14584949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design based on bioactive conformation analysis of pyrimidinylbenzoates as acetohydroxyacid synthase inhibitors by integrating molecular docking, CoMFA, CoMSIA, and DFT calculations.
    He YZ; Li YX; Zhu XL; Xi Z; Niu C; Wan J; Zhang L; Yang GF
    J Chem Inf Model; 2007; 47(6):2335-44. PubMed ID: 17887745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based 3D-QSAR studies on heteroarylpiperazine derivatives as 5-HT3 receptor antagonists.
    Zhou YJ; Zhu LP; Tang Y; Ye DY
    Eur J Med Chem; 2007 Jul; 42(7):977-84. PubMed ID: 17331624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies.
    Trossini GH; Guido RV; Oliva G; Ferreira EI; Andricopulo AD
    J Mol Graph Model; 2009 Aug; 28(1):3-11. PubMed ID: 19376735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.